CDC Website CDC Website

To Join the NPIN community or

You are here

Research Institutions

Delivering Comprehensive Services to Achieve HIV Epidemic Control in Subnational Units in Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR)

This follow-on FOA will sustain and enhance the delivery of comprehensive HIV/AIDS service packages in the Federal Republic of Nigeria. This will be accomplished by employing proven strategies and service delivery models to achieve and sustain epidemic control in Nigeria. This program will support facility and community based provision of HIV/AIDS prevention, treatment and support services in targeted geographic locations and populations.

Strengthening Care and Support Services for Highly Vulnerable Populations, Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Cote d'Ivoire under PEPFAR

CDC will, through this FOA, fund four (4) awards to build and improve upon a number of HIV community care and service activities supported by US CDC, including community-based care for adult and OVC activities managed by implementing partners under six separate agreements that are ending in March 2016.

Technical Assistance to India's National AIDS Control Program (NACP) for Strengthening Adult and Pediatric Anti-retroviral Treatment (ART) and Care Services Delivery Network under the President's Emergency Plan for AIDS Relief (PEPFAR)

This FOA is a 5 year project aimed at strengthening Adult and Pediatric care and ART service delivery under India’s National AIDS Control Program (NACP) through technical assistance for clinical mentoring, quality improvement and capacity building with a focus on geographic area as per the President's Emergency Plan For AIDS Relief (PEPFAR) India’s Country Operational Plan.

The Role of Dysbiosis in Cardiovascular, Pulmonary and Hematological Complications During HIV Infection (R01)

The purpose of this Funding Opportunity Announcement (FOA) is to invite basic research project grant applications for HIV Microbiome Centers to perform investigations on the role of HIV-induced dysbiosis and how this imbalance may induce and/or contribute to the occurrence of heart, lung, or blood (HLB) co-morbidities in HIV positive individuals. This FOA will support mechanistic studies that will use in vitro, in vivo, ex vivo, and in silico models applied to HIV research.

Jurisdictional Approach to Curing Hepatitis C Among HIV/HCV Coinfected People of Color - Evaluation and Technical Assistance ...

NPIN admin's picture
This announcement solicits applications for fiscal year 2016 Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Evaluation and Technical Assistance Center. Funding will be provided in the form of a cooperative agreement to support one (1) organization for up to three years to coordinate the efforts of up to four (4) Ryan White HIV/AIDS Program (RWHAP) Parts A and B recipients funded under a separate announcement (HRSA-16-189).

Understanding HIV Rebound (P01)

NPIN admin's picture
The purpose of this Funding Opportunity Announcement (FOA) is to support multi-disciplinary, Program Project applications aimed at understanding specific mechanisms, biomarkers, and pathways associated with rebound of HIV viremia.

Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R01)

NPIN admin's picture
This funding opportunity announcement invites research grant applications focused on: identifying HIV-1-infected cells in the central nervous system (CNS) compartment that are latently infected; developing strategies for targeting these latently infected cells; and aiming to achieve viral silencing leading to inhibition of viral production, without the need for pro-viral reactivation.

Advancing HIV Therapeutic Vaccine Science (U01)

NPIN admin's picture
This Funding Opportunity Announcement (FOA) solicits applications that will advance understanding of vaccine regimens and immune responses that sustainably suppress viral loads in HIV-infected individuals. Applications should propose small, multi-arm, comparative clinical trials designed to identify correlations between levels of induced immune response and HIV virologic control. Vaccines may be combined with adjuvants and/or other modifiers of the immune response to HIV.

Pages

Subscribe to RSS - Research Institutions